Gregory Russotti is Officer of Century Therapeutics, Inc.. Currently has a direct ownership of 274,933 shares of IPSC, which is worth approximately $316,172. The most recent transaction as insider was on Jul 26, 2024, when has been sold 586 shares (Common Stock) at a price of $2.5 per share, resulting in proceeds of $1,465. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 275K
0% 3M change
n/a 12M change
Total Value Held $316,172

Gregory Russotti Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 26 2024
SELL
Open market or private sale
$1,465 $2.5 p/Share
586 Reduced 0.21%
274,933 Common Stock
Jul 24 2024
SELL
Open market or private sale
$4,032 $2.52 p/Share
1,600 Reduced 0.58%
275,519 Common Stock
Jul 23 2024
SELL
Open market or private sale
$500 $2.5 p/Share
200 Reduced 0.07%
277,119 Common Stock
Jun 20 2024
SELL
Open market or private sale
$14,200 $2.84 p/Share
5,000 Reduced 1.77%
277,319 Common Stock
Jun 05 2024
SELL
Open market or private sale
$15,000 $3.0 p/Share
5,000 Reduced 1.74%
282,319 Common Stock
May 20 2024
SELL
Open market or private sale
$15,000 $3.0 p/Share
5,000 Reduced 1.71%
287,319 Common Stock
May 06 2024
SELL
Open market or private sale
$15,600 $3.12 p/Share
5,000 Reduced 1.68%
292,319 Common Stock
Apr 22 2024
SELL
Open market or private sale
$15,500 $3.1 p/Share
5,000 Reduced 1.65%
297,319 Common Stock
Mar 07 2024
BUY
Grant, award, or other acquisition
-
24,000 Added 7.35%
302,319 Common Stock
GR

Gregory Russotti

Officer
Philadelphia, PA

Track Institutional and Insider Activities on IPSC

Follow Century Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IPSC shares.

Notify only if

Insider Trading

Get notified when an Century Therapeutics, Inc. insider buys or sells IPSC shares.

Notify only if

News

Receive news related to Century Therapeutics, Inc.

Track Activities on IPSC